ACLARION, INC. Public Float
ACLARION, INC. (ACON) had Public Float of $4.39 million as of 2025-06-30, per its 10-K filed 2026-03-18.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-18
- 2025-06-30: Entity Public Float $4.39M.
- 2024-06-28: Entity Public Float $2.33M.
- 2023-06-30: Entity Public Float $4.67M.
- 2022-06-30: Entity Public Float $5.02M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $4.39M 10-K · filed 2026-03-18 |
| 2024-06-28 | $2.33M 10-K · filed 2025-04-09 |
| 2023-06-30 | $4.67M 10-K · filed 2024-03-28 |
| 2022-06-30 | $5.02M 10-K/A · filed 2023-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |